Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Breast Cancer|May 6, 2023
Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease CharacteristicsJoyce O'Shaughnessy, William Gradishar, Ruth O'Regan, et al.
Advances in Nutrition (Bethesda, Md.)|November 17, 2021
Current Evidence and Directions for Intermittent Fasting During Cancer ChemotherapyKelsey Gabel, Kate Cares, Krista Varady, et al.
Clinical Breast Cancer|June 9, 2023
Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020Ryan H Nguyen, Yomaira Silva, Jun Lu, et al.
The Breast Journal|March 14, 2018
Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancerEunpi Cho, Qian Wu, Lena Rubinstein, et al.
Chimerism|April 18, 2012
Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trialGhasem Solgi, Joannis Mytilineos, Vijayakrishna Gadi, et al.
Chimerism|May 4, 2013
Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survivalGhasem Solgi, Vijayakrishna Gadi, Biswajit Paul, et al.
Nutrition Reviews|August 27, 2024
Impact of Diet Modifications on Body Weight, Body Composition, Treatment Outcomes, and Quality of Life During Primary Treatment for Breast Cancer: A Systematic ReviewKaitlin Chakos, Lacey Pezley, Alyssa Bryner, et al.
JNCI Cancer Spectrum|October 24, 2024
Narrative review of lifestyle interventions in breast cancer survivors: current evidence and future directionsKelsey Gabel, Kaitlin Chakos, Manoela Lima Oliveira, et al.
Cancers|September 9, 2023
Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast CancerLaura C Kennedy, Anum S Kazerouni, Bonny Chau, et al.
Clinical Breast Cancer|February 10, 2019
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and ErlotinibLynn Symonds, Hannah Linden, Vijayakrishna Gadi, et al.
Pageof 2